Gyala Therapeutics Introduces First CAR-T Therapy Targeting CD84 for Treating Acute Leukemias Gyala Therapeutics has unveiled its first-in-class CAR-T therapy targeting CD84, demonstrating promising results in preclinical trials for leukemia.

Gyala Therapeutics Introduces First CAR-T Therapy Targeting CD84 for Treating Acute Leukemias #Spain #Barcelona #CAR-T_therapy #Gyala_Therapeutics #CD84_Target